tetano
Editor, Senior Moderator
J Med Virol
. 2021 Mar 31.
doi: 10.1002/jmv.26986. Online ahead of print.
Remdesivir for the treatment of COVID-19 in pregnancy
Dr Temi Lampejo[SUP] 1 [/SUP]
Affiliations
Abstract
The devastating coronavirus disease 2019 (COVID-19) global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared by the World Health Organisation (WHO) in March 2020 and now at over 9 months since its declaration it continues to claim vast numbers of lives all over the world. There is no evidence that pregnant women are more susceptible to SARS-CoV-2 infection than the general population, however, pregnancy-associated immunological changes could potentially render pregnant individuals more vulnerable to severe COVID-19. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; SARS-CoV-2; coronavirus; pregnant; remdesivir.
. 2021 Mar 31.
doi: 10.1002/jmv.26986. Online ahead of print.
Remdesivir for the treatment of COVID-19 in pregnancy
Dr Temi Lampejo[SUP] 1 [/SUP]
Affiliations
- PMID: 33788273
- DOI: 10.1002/jmv.26986
Abstract
The devastating coronavirus disease 2019 (COVID-19) global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared by the World Health Organisation (WHO) in March 2020 and now at over 9 months since its declaration it continues to claim vast numbers of lives all over the world. There is no evidence that pregnant women are more susceptible to SARS-CoV-2 infection than the general population, however, pregnancy-associated immunological changes could potentially render pregnant individuals more vulnerable to severe COVID-19. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; SARS-CoV-2; coronavirus; pregnant; remdesivir.